polatuzumab vedotin,rituximab
Roche
['polarix', 'dlbcl', 'lymphoma']
#ash22: on 12/11, alex f. herrera, m.d., will present prespecified analyses from the randomized, phase 3 polarix study. this work suggests that early changes in ctdna levels may be useful in designing future risk ctdna-adapted clinical trials. 
City of Hope is a National Cancer Institute-designated comprehensive cancer center for cancer, diabetes and other life-threatening diseases.